Identifying the critical domain of LL-37 involved in mediating neutrophil activation in the presence of influenza virus: Functional and structural analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Tripathi, Shweta ^a   Wang, Guangshun ^b   White, Mitchell ^a   Rynkiewicz, Michael ^a   Seaton, Barbara ^a   Hartshorn, Kevan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; GI 20; INTERLEUKIN 8; LL 23; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR; PEPTIDE FRAGMENT;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXTRACELLULAR TRAP; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLUENZA A VIRUS; LEUKOCYTE ACTIVATION; NONHUMAN; RESPIRATORY BURST; STRUCTURE ACTIVITY RELATION; BIOSYNTHESIS; CALCIUM SIGNALING; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; INFLUENZA A VIRUS (H3N2); INTRACELLULAR SPACE; METABOLISM; NEUTROPHIL; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; CALCIUM SIGNALING; EXTRACELLULAR TRAPS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERLEUKIN-8; INTRACELLULAR SPACE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; RESPIRATORY BURST;

EID: 84943339177     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133454     Document Type: Article

References (51)

1. Tripathi S, White MR, Hartshorn KL. The amazing innate immune response to influenza A virus infection. Innate Immun. 2015; 21(1):73-98. doi: 10.1177/1753425913508992 PMID: 24217220.
2. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005; 17(4):359-65. PMID: 15955682.
3. Gwyer Findlay E, Currie SM, Davidson DJ. Cationic Host Defence Peptides: Potential as Antiviral Therapeutics. BioDrugs. 2013. PMID: 23649937.
4. Gong T, Jiang Y, Wang Y, Yang D, Li W, Zhang Q, et al. Recombinant mouse beta-defensin 2 inhibits infection by influenza A virus by blocking its entry. Arch Virol. 2010; 155(4):491-8. PMID: 20195655.doi: 10.1007/s00705-010-0608-1
5. Jiang Y, Wang Y, Kuang Y, Wang B, Li W, Gong T, et al. Expression of mouse beta-defensin-3 in MDCK cells and its anti-influenza-virus activity. Arch Virol. 2009; 154(4):639-47. PMID: 19301094. doi: 10.1007/s00705-009-0352-6
6. Salvatore M, Garcia-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME. alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis. 2007; 196(6):835-43. PMID: 17703413.
7. Leikina E, Delanoe-Ayari H, Melikov K, Cho MS, Chen A, Waring AJ, et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat Immunol. 2005; 6 (10):995-1001. PMID: 16155572.
8. Tripathi S, Tecle T, Verma A, Crouch E, White M, Hartshorn KL. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. J Gen Virol. 2013; 94(Pt 1):40-9. doi: 10.1099/vir.0.045013-0 PMID: 23052388; PubMed Central PMCID: PMC3542722.
9. Doss M, White MR, Tecle T, Gantz D, Crouch EC, Jung G, et al. Interactions of alpha-, beta-, and thetadefensins with influenza A virus and surfactant protein D. J Immunol. 2009; 182(12):7878-87. PMID: 19494312. doi: 10.4049/jimmunol.0804049
10. Hartshorn KL, White MR, Tecle T, Holmskov U, Crouch EC. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol. 2006; 176(11):6962-72. PMID: 16709857.
11. Sweet C, Smith H. Pathogenicity of influenza virus. Microbiol Rev. 1980; 44:303-30. PMID: 6991901
12. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One. 2011; 6 (10):e25333. PMID: 22031815. doi: 10.1371/journal.pone.0025333
13. Gaudreault E, Gosselin J. Leukotriene B4 induces release of antimicrobial peptides in lungs of virally infected mice. J Immunol. 2008; 180(9):6211-21. PMID: 18424743 .
14. Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010; 87:79-92. PMID: 19808939. doi: 10.1189/jlb.0609382
15. Li HN, Barlow PG, Bylund J, Mackellar A, Bjorstad A, Conlon J, et al. Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol. 2009; 86(4):891-902. doi: 10.1189/jlb.0209050 PMID: 19581375; PubMed Central PMCID: PMC2791992.
16. Tecle T, White MR, Gantz D, Crouch EC, Hartshorn KL. Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses. J Immunol. 2007; 178(12):8046-52. PMID: 17548642.
17. Tripathi S, White MR, Wang G, Hartshorn K. LL-37 modulates human phagocyte responses to influenza A virus. 2014; 96: 931-8.
18. Mookherjee N, Wilson HL, Doria S, Popowych Y, Falsafi R, Yu JJ, et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide. J Leukoc Biol. 2006; 80(6):1563-74. PMID: 16943385.
19. De Y, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. LL-37, the neutrophil granuleand epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000; 192 (7):1069-74. PMID: 11015447.
20. Mookherjee N, Lippert DN, Hamill P, Falsafi R, Nijnik A, Kindrachuk J, et al. Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol. 2009; 183(4):2688-96. PMID: 19605696. doi: 10.4049/jimmunol.0802586
21. Zhang Z, Cherryholmes G, Chang F, Rose DM, Schraufstatter I, Shively JE. Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol. 2009; 39(11):3181-94. PMID: 19750480. doi: 10.1002/eji.200939496
22. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003; 171(12):6690-6. PMID: 14662872.
23. Nagaoka I, Tamura H, Hirata M. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol. 2006; 176(5):3044-52. PMID: 16493063.
24. Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol. 2004; 172(5):3070-7. PMID: 14978112.
25. Dannehl C, Gutsmann T, Brezesinski G. Surface activity and structures of two fragments of the human antimicrobial LL-37. Colloids and surfaces B, Biointerfaces. 2013; 109:129-35. doi: 10.1016/j.colsurfb.2013.03.030 PMID: 23624281.
26. Rico-Mata R, De Leon-Rodriguez LM, Avila EE. Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites. Experimental parasitology. 2013; 133 (3):300-6. doi: 10.1016/j.exppara.2012.12.009 PMID: 23274811.
27. Wang G, Elliott M, Cogen AL, Ezell EL, Gallo RL, Hancock RE. Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins. Biochemistry. 2012; 51(2):653-64. PMID: 22185690. doi: 10.1021/bi2016266
28. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem. 2008; 283(47):32637-43. PMID: 18818205. doi: 10.1074/jbc.M805533200
29. Wang G, Hanke ML, Mishra B, Lushnikova T, Heim CE, Chittezham Thomas V, et al. Transformation of human cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds. ACS chemical biology. 2014; 9(9):1997-2002. doi: 10.1021/cb500475y PMID: 25061850; PubMed Central PMCID: PMC4168778.
30. Jacob B, Park IS, Bang JK, Shin SY. Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. J Pept Sci. 2013; 19(11):700-7. doi: 10.1002/psc.2552 PMID: 24105706.
31. Wang G, Mishra B, Epand RF, Epand RM. High-quality 3D structures shine light on antibacterial, antibiofilm and antiviral activities of human cathelicidin LL-37 and its fragments. Biochim Biophys Acta. 2014; 1838(9):2160-72. doi: 10.1016/j.bbamem.2014.01.016 PMID: 24463069; PubMed Central PMCID: PMC4082733.
32. Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn KL. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. PLoS One. 2015; 10(4):e0124706. doi: 10.1371/journal.pone.0124706 PMID: 25909853; PubMed Central PMCID: PMC4409069.
33. Hartshorn KL, Collamer M, Auerbach M, Myers JB, Pavlotsky N, Tauber AI. Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol. 1988; 141(4):1295-301. PMID: 3135328
34. Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC. Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol. 1997; 273(6 Pt 1):L1156-66. PMID: 9435570.
35. Hartshorn KL, Collamer M, White MR, Schwartz JH, Tauber AI. Characterization of influenza A virus activation of the human neutrophil. Blood. 1990; 75(1):218-26. PMID: 2153030
36. Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC. Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J. 2000; 351 Pt 2:449-58. PMID: 11023831.
37. Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols. 2010; 5(4):725-38. doi: 10.1038/nprot.2010.5 PMID: 20360767; PubMed Central PMCID: PMC2849174.
38. Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science. 2013; 341(6152):1387-90. doi:10.1126/science.1241475 PMID: 24030490; PubMed Central PMCID: PMC3819204.
39. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, et al. Molecular control of delta-opioid receptor signalling. Nature. 2014; 506(7487):191-6. doi:10.1038/nature12944 PMID: 24413399; PubMed Central PMCID: PMC3931418.
40. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007; 318(5854):1258-65. doi: 10.1126/science.1150577 PMID: 17962520; PubMed Central PMCID: PMC2583103.
41. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, Vajda S. ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins. 2007; 69(4):781-5. doi: 10.1002/prot.21795 PMID: 17876812.
42. Hartshorn KL, Wright J, Collamer MA, White MR, Tauber AI. Human neutrophil stimulation by influenza virus: relationship of cytoplasmic pH changes to cell activation. Am J Physiol. 1990; 258(6 Pt 1): C1070-6. PMID: 2113768.
43. Tripathi S, Verma A, Kim EJ, White MR, Hartshorn KL. LL-37 modulates human neutrophil responses to influenza A virus. J Leukoc Biol. 2014. doi: 10.1189/jlb.4A1113-604RR PMID: 25082153.
44. Wan M, Godson C, Guiry PJ, Agerberth B, Haeggstrom JZ. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1. FASEB J. 2011; 25(5):1697-705. doi: 10.1096/fj.10-175687 PMID: 21307335.
45. Singh D, Qi R, Jordan JL, San Mateo L, Kao CC. The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway. J Biol Chem. 2013; 288(12):8258-68. doi: 10.1074/jbc.M112.440883 PMID: 23386607; PubMed Central PMCID: PMC3605644.
46. Douda DN, Khan MA, Grasemann H, Palaniyar N. SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc Natl Acad Sci U S A. 2015; 112 (9):2817-22. doi: 10.1073/pnas.1414055112 PMID: 25730848.
47. Daigneault DE, Hartshorn KL, Liou LS, Abbruzzi GM, White MR, Oh SK, et al. Influenza A virus binding to human neutrophils and cross-linking requirements for activation. Blood. 1992; 80(12):3227-34. PMID: 1334733.
48. Hartshorn KL, Reid KB, White MR, Jensenius JC, Morris SM, Tauber AI, et al. Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood. 1996; 87(8):3450-61. PMID: 8605364.
49. Buss NA, Gavins FN, Cover PO, Terron A, Buckingham JC. Targeting the annexin 1-formyl peptide receptor 2/ALX pathway affords protection against bacterial LPS-induced pathologic changes in the murine adrenal cortex. FASEB J. 2015. doi: 10.1096/fj.14-268375 PMID: 25818588.
50. Le Y, Yang Y, Cui Y, Yazawa H, Gong W, Qiu C, et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol. 2002; 2(1):1-13. PMID: 11789660.
51. Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn K. Antiviral activity of the human cathelicidin, LL-37, and derived peptides on seasonal and pandemic influenza A virus. PLOS One. 2015; e0214706.